VUMC research aids approval of COVID-19 vaccine for young children

Jun. 16, 2022—The U.S. Food and Drug Administration is expected to authorize Pfizer and Moderna’s COVID-19 vaccines for children as young as 6 months old as early as tomorrow, following the unanimous recommendation by an FDA advisory panel on Wednesday.

Read more